Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection.

作者: W. H. F. Goessens , J. W. Mouton , M. T. ten Kate , A. J. Bijl , A. Ott

DOI: 10.1093/JAC/DKL529

关键词: MicrobiologyCeftazidimeAgar plateEnterobacter cloacaeBiologyKlebsiella pneumoniaePharmacodynamicsEnterobacteriaceaeAntibacterial agentAntibiotics

摘要: Objectives: The effect of ceftazidime dosing increments and frequency on the selection ceftazidime-resistant Enterobacter cloacae in intestine was studied rats, during treatment a pulmonary infection caused by Klebsiella pneumoniae. Methods: Rats with (n 5 10 per group) received therapy doses at 3.1 to 400 mg/kg day every 6,12 or 24 h for 18 days, starting after bacterial inoculation lung. Emergence resistance intestinal E. monitored culturing fresh stool specimens days 0, 8, 15, 22, 29, 36 43 agar plates (6.4 mg/L) without ceftazidime. Pharmacodynamic indices time within mutant window (MSW) were assessed infected rats each regimen. Ceftazidime-resistant mutants characterized determination β-lactamase activity under cefoxitin-induced non-induced conditions. Results: A reduction ceftazidime-susceptible observed showed significant correlation fAUC/MIC 15 22 fCmaxon 29 36. More treated 12-25 50-100 6 found colonized than animals 12 h. proportion correlated which plasma concentrations boundaries MSW. Only demonstrated between fCmaxand significantly fewer cloacae. (MIC ≥ 128 as stable derepressed mutants. Conclusions: Colonization particularly occurred when exposed moderate (12-25 day) administered

参考文章(33)
J.M. Blondeau, G. Hansen, K. Metzler, P. Hedlin, The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration. Journal of Chemotherapy. ,vol. 16, pp. 1- 19 ,(2004) , 10.1080/1120009X.2004.11782371
Larry H. Danziger, Stephen C. Piscitelli, Douglas N. Fish, Development of Resistance During Antimicrobial Therapy: A Review of Antibiotic Classes and Patient Characteristics in 173 Studies Pharmacotherapy. ,vol. 15, pp. 279- 291 ,(1995) , 10.1002/J.1875-9114.1995.TB04366.X
C. H. O'Callaghan, A. Morris, S. M. Kirby, A. H. Shingler, Novel Method for Detection of β-Lactamases by Using a Chromogenic Cephalosporin Substrate Antimicrobial Agents and Chemotherapy. ,vol. 1, pp. 283- 288 ,(1972) , 10.1128/AAC.1.4.283
David C. Perlman, Wafaa M. El Sadr, Leonid B. Heifets, Eileen T. Nelson, John P. Matts, Keith Chirgwin, Nadim Salomon, Edward E. Telzak, Oscar Klein, Barry N. Kreiswirth, James M. Musser, Richard Hafner, Susceptibility to levofloxacin of Mycobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance AIDS. ,vol. 11, pp. 1473- 1478 ,(1997) , 10.1097/00002030-199712000-00011
D. M. Flynn, R. A. Weinstein, C. Nathan, M. A. Gaston, S. A. Kabins, Patients' Endogenous Flora as the Source of “Nosocomial” Enterobacter in Cardiac Surgery The Journal of Infectious Diseases. ,vol. 156, pp. 363- 368 ,(1987) , 10.1093/INFDIS/156.2.363
Manuel Etienne, Delphine Croisier, Pierre‐Emmanuel Charles, Catherine Lequeu, Lionel Piroth, Henri Portier, Karl Drlica, Pascal Chavanet, Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits. The Journal of Infectious Diseases. ,vol. 190, pp. 1472- 1475 ,(2004) , 10.1086/423853
I A Bakker-Woudenberg, J C van den Berg, M F Michel, Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats. Antimicrobial Agents and Chemotherapy. ,vol. 22, pp. 1042- 1050 ,(1982) , 10.1128/AAC.22.6.1042